Akero Therapeutics
AKRO
#4278
Rank
A$3.25 B
Marketcap
$46.69
Share price
-3.51%
Change (1 day)
42.23%
Change (1 year)

Akero Therapeutics (AKRO) Fails to deliver data

Key failure to deliver metrics for Akero Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Akero Therapeutics (AKRO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Akero Therapeutics (AKRO) - since 2019

Volume in USD (price x number of shares), data since 2019

Akero Therapeutics (AKRO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$5.99 M-58.67%
2023A$14.49 M-3.77%
2022A$15.06 M105.18%
2021A$7.34 M-52.08%
2020A$15.32 M114.88%
2019A$7.12 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
A$1 MA$6 M๐Ÿ‡บ๐Ÿ‡ธ USA